- Home
- CRBU vs UYSC Comparison
CRBU vs UYSC Comparison
Compare CRBU & UYSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- UYSC
- Stock Information
- Founded
- CRBU 2011
- UYSC 2024
- Country
- CRBU United States
- UYSC United States
- Employees
- CRBU N/A
- UYSC N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- UYSC Blank Checks
- Sector
- CRBU Health Care
- UYSC Finance
- Exchange
- CRBU Nasdaq
- UYSC Nasdaq
- Market Cap
- CRBU 93.0M
- UYSC 76.3M
- IPO Year
- CRBU 2021
- UYSC 2025
- Fundamental
- Price
- CRBU $1.36
- UYSC $10.02
- Analyst Decision
- CRBU Strong Buy
- UYSC
- Analyst Count
- CRBU 4
- UYSC 0
- Target Price
- CRBU $8.50
- UYSC N/A
- AVG Volume (30 Days)
- CRBU 1.2M
- UYSC 17.6K
- Earning Date
- CRBU 08-05-2025
- UYSC 01-01-0001
- Dividend Yield
- CRBU N/A
- UYSC N/A
- EPS Growth
- CRBU N/A
- UYSC N/A
- EPS
- CRBU N/A
- UYSC N/A
- Revenue
- CRBU $9,918,000.00
- UYSC N/A
- Revenue This Year
- CRBU $12.83
- UYSC N/A
- Revenue Next Year
- CRBU N/A
- UYSC N/A
- P/E Ratio
- CRBU N/A
- UYSC N/A
- Revenue Growth
- CRBU N/A
- UYSC N/A
- 52 Week Low
- CRBU $0.66
- UYSC $10.05
- 52 Week High
- CRBU $3.00
- UYSC $11.00
- Technical
- Relative Strength Index (RSI)
- CRBU 62.05
- UYSC N/A
- Support Level
- CRBU $1.12
- UYSC N/A
- Resistance Level
- CRBU $1.33
- UYSC N/A
- Average True Range (ATR)
- CRBU 0.11
- UYSC 0.00
- MACD
- CRBU 0.00
- UYSC 0.00
- Stochastic Oscillator
- CRBU 79.49
- UYSC 0.00
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About UYSC UY Scuti Acquisition Corp. Ordinary Shares
UY Scuti Acquisition Corp is a newly organized blank check company.